Africa & Middle East

Families need to understand their benefits, coverage limits, exclusions and potential out-of-pocket expenses, particularly when cancer treatment involves additional costs such as transportation, caregiving and lost income.

The initial rollout will cover all five provinces, including the City of Kigali, and provide an alternative to daily oral pre-exposure prophylaxis (PrEP).

If proven safe and effective, long-acting injectable (LAI) could complement current interventions, including insecticide-based vector control, malaria vaccines and preventive medicines.

Portfolio Pharmaceuticals Botswana has completed a technology transfer from an international manufacturing partner, equipping local specialists with the skills needed to formulate, manufacture, and test medicines while maintaining quality standards.

The facility is being developed next to the Shoe4Africa Children’s Hospital, Riley Mother and Baby Hospital, and MTRH’s Mental Health and Rehabilitative Services Unit.

Relocated to the hospital’s former casualty area, the clinic provides a larger workspace for patient navigators to coordinate referrals, appointments and follow-up care.

The project will cost €33.58 million (US$38.8 million), with the French loan covering approximately 95% of the investment and the Ugandan government providing the remaining €1.6 million (US$1.85 million).

According to the World Health Organization’s (WHO) World Malaria Report 2025, an estimated 282 million malaria cases and 610,000 deaths occurred worldwide in 2024.

Although genome sequencing has expanded worldwide, scientists still lack a clear understanding of how many genetic variations affect gene activity and contribute to disease.

The event, organised by SEHA, a subsidiary of PureHealth, will take place under the patronage of the Ruler’s Representative Court in Al Dhafra Region.